184 related articles for article (PubMed ID: 15630040)
1. Drug therapy in the heart transplant recipient: Part III: common medical problems.
Lindenfeld J; Page RL; Zolty R; Shakar SF; Levi M; Lowes B; Wolfel EE; Miller GG
Circulation; 2005 Jan; 111(1):113-7. PubMed ID: 15630040
[No Abstract] [Full Text] [Related]
2. Drug therapy in the heart transplant recipient: part IV: drug-drug interactions.
Page RL; Miller GG; Lindenfeld J
Circulation; 2005 Jan; 111(2):230-9. PubMed ID: 15657387
[No Abstract] [Full Text] [Related]
3. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
4. [Integrated drug therapy of the metabolic syndrome].
Julius U; Hanefeld M
Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
[No Abstract] [Full Text] [Related]
5. Association between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugs.
Sirois C; Moisan J; Poirier P; Couture J; Gregoire JP
Age Ageing; 2009 Nov; 38(6):741-5. PubMed ID: 19759258
[No Abstract] [Full Text] [Related]
6. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
Isaacsohn JL; Troendle AJ; Orloff DG
Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
[No Abstract] [Full Text] [Related]
7. Basic approach to managing hyperglycemia for the nonendocrinologist.
Deeg MA
Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
[TBL] [Abstract][Full Text] [Related]
8. New drug update: 2011.
Hussar DA
Consult Pharm; 2012 Apr; 27(4):224-37. PubMed ID: 22498984
[TBL] [Abstract][Full Text] [Related]
9. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
Onuchin SG; Elsukova OS; Onuchina EL
Klin Med (Mosk); 2008; 86(8):61-6. PubMed ID: 18819351
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
Rehring TF; Stolcpart RS; Hollis HW;
J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
[TBL] [Abstract][Full Text] [Related]
11. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
[No Abstract] [Full Text] [Related]
12. Hypertension after heart transplantation: predictive factors and number and classes of drugs for its management.
Sánchez Lázaro IJ; Almenar Bonet L; Martínez-Dolz L; Moro López J; Ramón-Llín JA; Pérez OC; Soriano JR; Fuentes FB; Manchón JN; Sánchez Gómez JM; Sanz AS
Transplant Proc; 2008 Nov; 40(9):3051-2. PubMed ID: 19010190
[TBL] [Abstract][Full Text] [Related]
13. Medication considerations for patients with chronic kidney disease who are not yet on dialysis.
Liles AM
Nephrol Nurs J; 2011; 38(3):263-70. PubMed ID: 21877459
[TBL] [Abstract][Full Text] [Related]
14. Gout, bradycardia, and hypercholesterolemia after renal transplantation.
Kelleher SP; Davis WR; Paraskevopoulos N
South Med J; 2001 Jul; 94(7):732-4. PubMed ID: 11531183
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
Piechowski-Jóźwiak B; Bogousslavsky J
Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
[TBL] [Abstract][Full Text] [Related]
16. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
Beevers DG; Lee KW; Lip GY
J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
[No Abstract] [Full Text] [Related]
17. [Diabetes mellitus and cerebrovascular disorders].
Udaka F
Nihon Rinsho; 2002 Oct; 60 Suppl 10():336-41. PubMed ID: 12430250
[No Abstract] [Full Text] [Related]
18. Managing risk factors for atherosclerosis in critical limb ischaemia.
Gottsäter A
Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
Okunevich IV; Khnychenko LK; Sapronov NS
Klin Med (Mosk); 2007; 85(1):52-7. PubMed ID: 17419357
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
Sirois C; Moisan J; Poirier P; Grégoire JP
Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
